Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
Device and method for processing input data of protective relay
Method for manufacturing a turbine engine vane
System for and method of remotely auditing inventoried assets
Transparent conductive structure
Flat display panel and method for forming the same
Method, system and program for securing redundancy in parallel computing system
  Randomly Featured Patents
Endovascular graft joint and method for manufacture
Process for in-line forming of pultruded composites
Method for in mold trimming
Non-coherent direct sequence spread spectrum receiver for detecting bit/symbol chip sequences using threshold comparisons of chip sequence correlations
Two station, single action vise
Electro-optical device, electronic apparatus, and method for manufacturing electro-optical device
Subsurface drainage system and drain structure therefor
Techniques for forming a connection between a pin and a circuit board
Sewing machine console having a lowering device